Arena Pharma raises $33M

Arena Pharmaceuticals ($ARNA) is raising $33 million in a stock sale. Deerfield Management, a healthcare investment organization, is buying the shares for $1.65 each. Arena recently submitted new information to the FDA for its obesity drug lorcaserin, hoping to become the first drug developer to win an approval for a weight drug in more than a decade. Arena release

Suggested Articles

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.

The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.